The 7.5% organic growth in North America is particularly noteworthy given the competitive landscape. Historically, the North American market is the most lucrative but also the most volatile for global holding companies. In 2026, many agencies have struggled to find growth in the U.S. and Canada as tech giants and telecommunications firms—traditional heavy spenders—recalibrated their marketing investments. Havas’s ability to buck this trend suggests a particularly strong performance from its North American leadership and a client roster that may be less susceptible to the specific pressures affecting its competitors.
Industry analysts point to Havas’s strength in the healthcare and pharmaceutical sectors as a potential reason for this regional success. Havas Health & You, the group’s global health network, has a significant footprint in the United States, and the healthcare sector typically remains more resilient during economic fluctuations than consumer packaged goods or luxury retail. Furthermore, the agency’s focus on "meaningful brands"—a proprietary research-led approach to building brand equity—appears to be winning over North American clients who are increasingly focused on purpose-driven marketing and measurable consumer impact.
Watercooler Talk
The conversation across the advertising industry this quarter has centered on the divergence between Havas and its larger peers. While the broader market has been characterized by "flat is the new up" sentiment in North America, Havas’s 7.5% jump has become a primary point of discussion. This disparity highlights a potential shift in the competitive order, suggesting that Havas’s mid-sized agility, combined with the backing of its parent company, is allowing it to navigate the current market more effectively than some of the more fragmented holding companies.
The focus now shifts to the fourth quarter and the start of 2027. With eight acquisitions already under its belt this year, the industry is watching to see if Havas will continue its shopping spree or pivot toward a period of consolidation to fully harvest the synergies of its new assets. The projected 2% to 3% organic growth for the full year is a realistic target, but if North America continues to perform at its current level, some insiders wonder if Havas might end the year at the higher end of that range.
As the company prepares for the final months of 2026, the emphasis will likely remain on maintaining the momentum in the U.S. while attempting to re-energize growth in Europe and Asia. The 2026 results so far paint a picture of a company that is successfully balancing the need for immediate scale through acquisitions with the long-term necessity of organic vitality. In a year that has tested the mettle of the world’s largest marketing organizations, Havas appears to have found a formula that keeps it moving forward, even as the global economic tailwinds begin to shift.
